We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Upper, Lower Federal Courts Favor Sandoz in Amgen Biosimilar Patent Rulings
Upper, Lower Federal Courts Favor Sandoz in Amgen Biosimilar Patent Rulings
Sandoz triumphed over Amgen in a biosimilar patent infringement case that went from a Northern California federal court, up the ladder to the Supreme Court and back down again — following victories in both the district court and the Federal Circuit Court of Appeals this past week.